Skip to content

Clinical trials

Observational Coronary Artery Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Observational Country / region: United States Clear all

353 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20036
20047
20055
200616
200717
200822
200920
201032
201119
201220
201318
201413
201518
201617
201719
201810
201918
202012
202112
20227
20237
202410
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed232
Terminated29
Unknown status25
Recruiting21
Withdrawn17
Active, not recruiting15
Not yet recruiting7
Enrolling by invitation5
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)16
Abbott Medical Devices15
CardioDx10
Corewell Health East10
Emory University9
Icahn School of Medicine at Mount Sinai8
Mayo Clinic7
Boston Scientific Corporation6
HeartFlow, Inc.6
Brigham and Women's Hospital5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease353
Coronary Disease40
Atherosclerosis32
Cardiovascular Diseases32
Chest Pain31
Myocardial Infarction28
Heart Diseases27
Myocardial Ischemia26
Angina Pectoris24
Acute Coronary Syndrome14

Trials

Showing 1 to 25 of 353. Each trial links to its page on Pharma Observatory.

253 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.